Bruker Corp. (NASDAQ:BRKR) Given Average Recommendation of “Hold” by Brokerages
Bruker Corp. (NASDAQ:BRKR) has received a consensus recommendation of “Hold” from the twenty-one research firms that are presently covering the stock. One equities research analyst has rated the stock with a sell rating, twelve have given a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year is $25.67.
Several equities research analysts have issued reports on BRKR shares. Janney Montgomery Scott raised Bruker Corp. from a “neutral” rating to a “buy” rating and set a $28.00 target price for the company in a research note on Wednesday, August 3rd. Wells Fargo & Co. cut Bruker Corp. from an “outperform” rating to a “market perform” rating in a research note on Wednesday, August 3rd. Mizuho cut their target price on Bruker Corp. from $28.00 to $23.00 and set a “neutral” rating for the company in a research note on Wednesday, August 3rd. Zacks Investment Research cut Bruker Corp. from a “buy” rating to a “hold” rating in a research note on Tuesday, July 5th. Finally, Morgan Stanley set a $23.00 target price on Bruker Corp. and gave the stock a “hold” rating in a research note on Wednesday, August 3rd.
In other Bruker Corp. news, Director Richard A. Packer purchased 10,000 shares of the firm’s stock in a transaction on Wednesday, August 10th. The stock was bought at an average cost of $21.97 per share, with a total value of $219,700.00. Following the acquisition, the director now directly owns 22,500 shares of the company’s stock, valued at $494,325. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Frank H. Laukien purchased 4,500 shares of the firm’s stock in a transaction on Friday, August 5th. The shares were acquired at an average cost of $22.17 per share, with a total value of $99,765.00. Following the completion of the acquisition, the chief executive officer now directly owns 37,658,733 shares in the company, valued at $834,894,110.61. The disclosure for this purchase can be found here. Company insiders own 35.80% of the company’s stock.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/10/10/bruker-corp-nasdaqbrkr-given-average-recommendation-of-hold-by-brokerages.html
A number of hedge funds have recently made changes to their positions in the company. GSA Capital Partners LLP boosted its stake in Bruker Corp. by 86.0% in the second quarter. GSA Capital Partners LLP now owns 150,990 shares of the company’s stock worth $3,434,000 after buying an additional 69,804 shares during the period. Geode Capital Management LLC boosted its stake in Bruker Corp. by 32.0% in the first quarter. Geode Capital Management LLC now owns 919,127 shares of the company’s stock worth $25,734,000 after buying an additional 222,648 shares during the period. UBS Group AG boosted its stake in Bruker Corp. by 10.0% in the first quarter. UBS Group AG now owns 76,502 shares of the company’s stock worth $2,142,000 after buying an additional 6,967 shares during the period. Meeder Asset Management Inc. purchased a new stake in Bruker Corp. during the first quarter worth approximately $355,000. Finally, State Street Corp boosted its stake in Bruker Corp. by 27.2% in the first quarter. State Street Corp now owns 1,527,696 shares of the company’s stock worth $42,770,000 after buying an additional 326,527 shares during the period. 69.92% of the stock is owned by institutional investors.
Shares of Bruker Corp. (NASDAQ:BRKR) traded down 0.18% during midday trading on Monday, hitting $22.35. The company had a trading volume of 156,819 shares. The firm has a market capitalization of $3.60 billion, a PE ratio of 33.66 and a beta of 0.93. Bruker Corp. has a 12 month low of $16.61 and a 12 month high of $29.85. The company has a 50-day moving average of $22.30 and a 200 day moving average of $24.87.
Bruker Corp. (NASDAQ:BRKR) last posted its earnings results on Tuesday, August 2nd. The company reported $0.20 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.20. The company earned $371.70 million during the quarter, compared to analysts’ expectations of $409.57 million. Bruker Corp. had a return on equity of 22.66% and a net margin of 6.86%. The firm’s quarterly revenue was down 6.1% compared to the same quarter last year. During the same quarter last year, the firm earned $0.19 earnings per share. On average, analysts expect that Bruker Corp. will post $1.00 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which was paid on Friday, September 23rd. Shareholders of record on Tuesday, September 6th were issued a dividend of $0.04 per share. This represents a $0.16 dividend on an annualized basis and a yield of 0.72%. The ex-dividend date of this dividend was Thursday, September 1st. Bruker Corp.’s dividend payout ratio (DPR) is 24.24%.
About Bruker Corp.
Bruker Corporation is a designer and manufacturer of scientific instruments, and analytical and diagnostic solutions. The Company’s operating segments include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies (BEST) Segment.
Receive News & Ratings for Bruker Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker Corp. and related companies with MarketBeat.com's FREE daily email newsletter.